Astellas buys eye gene therapy biotech Quethera for $109mJapanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused Share XAstellas buys eye gene therapy biotech Quethera for $109mhttps://pharmaphorum.com/news/astellas-expands-ocular-gene-therapy-investment/
